Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.

2013

Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL S447X ) gene therapy for lipoprotein lipase deficiency: an open-label trial

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

38

References

295

Citations